Beranda › Mieloma Multipel › Kansas › Kansas City
Uji klinis Mieloma Multipel di Kansas City, KS
4 studi untuk Mieloma Multipel mencari peserta di lokasi sekitar Kansas City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Menerima pesertaFase 3
- Research Site, Kansas City
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 3
- University of Kansas Cancer Center, Kansas City
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 1
- University of Kansas Cancer Center, Kansas City
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Menerima pesertaFase 3
- American Oncology Partners, P.A. Dba MidAmerica Cancer Care, Kansas City
Uji klinis Mieloma Multipel di kota lain
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA41 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- Rochester, MN24 studi
- St. Louis, MO24 studi
- Columbus, OH24 studi
- Baldwin Park, CA23 studi
- Chicago, IL22 studi
Studi lain di Kansas City
- Penyakit Kardiovaskular14 studi
- Penyakit Paru Interstisial13 studi
- Gagal Jantung13 studi
- Obesitas13 studi
- Fibrosis Kistik13 studi
- Kanker Kandung Kemih12 studi
- Kanker Prostat12 studi
- Kanker Payudara12 studi
- Kanker Paru Non-Sel Kecil11 studi
- Leukemia Mieloid Akut11 studi
- Kanker Paru11 studi
- PPOK9 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.